37 hasil untuk "Moritz Binder"
Menampilkan 1–20 · 0,88 detik · RSS
-
Artikel Jurnal
Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes
Abstract The natural history of multiple myeloma is characterized by its localization to the bone marrow and its interaction with bone marrow stromal cells. The bone marrow stromal cells provide growth and survival signals, thereby promoting the development of drug resistance. Here, we show that…
-
Artikel Jurnal
Extramedullary myeloma is genomically complex and characterized by near-universal MAPK pathway alterations
Abstract: Extramedullary disease (EMD) is associated with an inferior prognosis and lower response rates to conventional multiple myeloma (MM)–directed therapies compared to MM without EMD. A deeper understanding of the molecular landscape and underlying drivers of EMD is essential to identify…
-
Artikel Jurnal
Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide
Abstract Background/purpose Elevated levels of C-reactive protein (CRP) in systemic sclerosis (SSc) have been linked to early inflammatory stages of the disease. This study has been designed to investigate CRP levels longitudinally in a cohort of SSc patients and to correlate these findings with…
-
Artikel Jurnal
The ratio of brain to liver glucose activity and disease activity in multiple myeloma
Abstract Changes in metabolic activity in tumor cells is one of the hallmarks of cancer. Cancer cells exhibit the Warburg effect with high glucose consumption for their energy needs. This provides the basis for imaging using 18F-2-deoxy-D-glucose for positron emission tomography to assess tumor…
-
Artikel Jurnal
Mode of progression in smoldering multiple myeloma: a study of 406 patients
Abstract The approach to patients with high-risk smoldering multiple myeloma (SMM) varies among clinicians; while some advocate early intervention, others reserve treatment at progression to multiple myeloma (MM). We aimed to describe the myeloma-defining events (MDEs) and clinical presentations…
-
Artikel Jurnal
Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia
‘Mutations in the chromatin remodeler ASXL1 (ASXL1MT) are associated with poor clinical outcome, however, their impact on chromatin dynamics remains unexplored. Here the authors use a multi-omics approach for chronic myelomonocytic leukemia (CMML) and investigate the transcriptome and chromatin…
-
Artikel Jurnal
From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis
Abstract: This retrospective analysis examined 15 years of autologous stem cell transplantation (ASCT) for light chain (AL) amyloidosis at the Mayo Clinic (2010-2024). We aimed to assess ASCT utilization trends, factors influencing practice changes, and current indications amid newer therapies…
-
Artikel Jurnal
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma
Abstract Allogeneic stem cell transplant (allo SCT) for multiple myeloma (MM) is potentially curative in some, while toxic in many others. We retrospectively analyzed 85 patients diagnosed with MM who underwent allo SCT as frontline or salvage therapy between 2000 and 2022 at Mayo Clinic Rochester…
-
Artikel Jurnal
Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic response
Cardiac response (CarR) is associated with survival in AL amyloidosis, but substantial variation exists in response kinetics. We investigated variables associated with deep CarRs to characterize the factors that govern organ recovery. Retrospective study of newly-diagnosed AL amyloidosis patients…
-
Artikel Jurnal
CAR T-cell therapy outcomes in plasma cell leukemia
Abstract: Plasma cell leukemia (PCL) is a rare and aggressive plasma cell disorder with poor outcomes. We retrospectively evaluated 26 patients with primary PCL (n = 21) or secondary PCL (n = 5) treated with anti–B-cell maturation antigen–directed chimeric antigen receptor T-cell (CAR-T…
-
Artikel Jurnal
Conditional survival in multiple myeloma and impact of prognostic factors over time
Abstract Overall survival estimates from diagnosis are valuable for guiding treatment, but do not consider the years already survived. Conditional survival (CS) provides dynamic survival predictions over time. This study was conducted to estimate CS at 1–8 years from diagnosis and the impact of…
-
Artikel Jurnal
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis
Abstract Uniform assessment of response to treatment is crucial to managing multiple myeloma (MM) and developing new therapies. Measurement of monoclonal protein forms the cornerstone of disease assessment in MM. According to International Myeloma Working Group (IMWG) guidelines, serum-free light…
-
Artikel Jurnal
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide
Abstract Refractoriness to lenalidomide is an important factor determining the choice of therapy at first relapse in multiple myeloma (MM). It remains debatable if resistance to lenalidomide varies among MM refractory to standard doses vs low dose maintenance doses. In this study, we assessed the…